Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
80,507,922
-
Share change
-
+9,111,889
-
Total reported value
-
$673,026,736
-
Put/Call ratio
-
582%
-
Price per share
-
$8.36
-
Number of holders
-
132
-
Value change
-
+$71,549,648
-
Number of buys
-
77
-
Number of sells
-
47
Institutional Holders of ENDOLOGIX INC - COM (ELGX) as of Q1 2016
As of 31 Mar 2016,
ENDOLOGIX INC - COM (ELGX) was held by
132 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
80,507,922 shares.
The largest 10 holders included
JANUS CAPITAL MANAGEMENT LLC, CADIAN CAPITAL MANAGEMENT, LP, VANGUARD GROUP INC, Arrowpoint Asset Management, LLC, GOLDMAN SACHS GROUP INC, Camber Capital Management LLC, Tamarack Advisers, LP, WELLINGTON MANAGEMENT GROUP LLP, Clearbridge Investments, LLC, and TimesSquare Capital Management, LLC.
This page lists
132
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.